The Leukemia & Lymphoma Society (LLS) is closely monitoring the coronavirus (COVID-19) pandemic.
One of our highest priorities is the well-being of our employees, volunteers, donors, partners, and the patients we serve – especially as many blood cancer patients are immunocompromised.
As a health organization, LLS takes seriously our responsibility to help slow the spread of the coronavirus (COVID-19) and protect the communities we serve. As such, we are postponing our in-person fundraising events, and postponing in-person events for patients, caregivers and healthcare professionals. LLS remains open for business, although our offices are closed and our staff is working from home. When possible, we will provide virtual opportunities to continue to drive forward our important mission work.
We are following vigilantly guidance from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and local public health officials as we continue to evaluate our plans and act in a timely and responsible way.
In these times of uncertainty, blood cancer patients and their families need our help more than ever. We're committed to working tirelessly toward our mission each and every day. To address their unique concerns during this time, LLS will amplify our efforts to provide free information and support to blood cancer patients and their families. We will also advocate for policies that will protect patients.
We encourage patients who have specific questions or concerns to speak directly with their doctors and care team. Our Information Specialists – master's level oncology professionals who provide free, personalized assistance to patients, families and healthcare providers – are available to speak one-on-one with patients and caregivers. Patients and caregivers can call (800) 955-4572 from Monday to Friday, 9 a.m. to 9 p.m. ET or visit www.lls.org/support/information-specialists
For more information, you can read the latest LLS news and blogs posts:
COVID-19 Vaccines FAQ for Patients and Caregivers by Gwen Nichols, MD, LLS Chief Medical Officer
Helping Blood Cancer Patients and Families When It's Needed Most by Gwen Nichols, MD, LLS Chief Medical Officer
Driving Forward Our COVID-19 Policy Priorities for Patients By Ryan Holeywell, Senior Director, Advocacy Communication
Recent Drug Approvals for Blood Cancer Mark Significant Progress for Patients by Lee Greenberger, PhD, Chief Scientific Officer, LLS
Working with Lawmakers to Address the Unique Needs of Cancer Patients by Ryan Holeywell, Senior Director, Advocacy Communication at LLS
Staying Well-Nourished While Social Distancing by Abby Singh, Sr. Manager, Patient Programs & Content, & Margaret Martin, Registered Dietitian, at LLS
More COVID-19 Questions and Answers by Gwen Nichols, MD, LLS Chief Medical Officer
10 Self-Care Tips to Cope with Isolation and Stress by Gwen Nichols, MD, LLS Chief Medical Officer
Helping Blood Cancer Patients Adjust to the New Normal by Gwen Nichols, MD, LLS Chief Medical Officer
4 Things Cancer Patients Need To Know About The Coronavirus by Gwen Nichols, MD, LLS Chief Medical Officer
News Releases & Statements:
Connect Science: Virtually Connecting The Science Community
The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute are hosting a series of webinars by leading cancer researchers, including LLS-supported researchers Catherine Wu, Ben Ebert and Carl June and others. Click here to view the webinars in real time, view archived sessions, and see the schedule of upcoming presenters. The talks are focused on science but anyone interested is welcome to join.